IGF1 and triple-negative breast carcinoma: Continuous treatment with the IGF-Trap may have selected cells with upregulated compensatory survival and growth mechanisms that rescued the cells from IGF-signaling blockade, as we have previously found for triple negative breast cancer cells [38].